China BlueChemical Ltd. Reports 3% Decline in First-Half 2025 Revenue to RMB5.85 Billion; Net Profit at RMB641 Million

Reuters
2025/09/29
China BlueChemical Ltd. Reports 3% Decline in First-Half 2025 Revenue to RMB5.85 Billion; Net Profit at RMB641 Million

China BlueChemical Ltd. reported its financial results for the six months ended 30 June 2025. The company recorded revenue of RMB 5.85 billion, compared to RMB 6.01 billion in the same period last year. Gross profit for the period was RMB 847.88 million, down from RMB 1.00 billion in the prior year. Net profit for the period was RMB 723.77 million, compared to RMB 743.37 million in the first half of 2024. Profit attributable to owners of the company was RMB 640.56 million, compared to RMB 686.83 million a year earlier. Basic and diluted earnings per share for the period were reported at RMB 0.14, compared to RMB 0.15 in the prior period. Finance income for the period was RMB 162.91 million, while finance costs totaled RMB 24.45 million. The company reported a net gain of RMB 83.72 million in other gains and losses, and a net exchange gain of RMB 0.82 million. Share of profits of joint ventures increased to RMB 61.03 million from RMB 3.04 million in the first half of 2024, while share of profits of associates was RMB 4.26 million, up from RMB 1.38 million a year ago. There were no significant updates regarding business operations included in the reported results.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China BlueChemical Ltd. published the original content used to generate this news brief on September 29, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10